Диссертация (1140961), страница 14
Текст из файла (страница 14)
Rev. – 2011. –Vol. 91. – Р. 151–175.72.Ferreira C.M., Vieira A.T., Vinolo M.A. The Central Role of the Gut Microbiotain Chronic Inflammatory Diseases // J. Immunol. Res. – 2014. – Vol. 689492. –Р. 10–12.73.Fiocchi A., Pawankar R., Cuello-Garcia C. et al. World Allergy OrganizationMcMaster University Guidelines for allergic disease prevention (GLAD-P):probiotics // World Allergy Organ J. – 2015. – Vol. 8(1).
– Р. 4–10.74.Flint H.J., Scott K., Duncan S.H. Microbial degradation of complexcarbohydrates in the gut // Gut. Microbes. – 2012. – Vol. 3, №4. – P. 289–306.75.Ganesh В.Р., Versalovic J. Luminal Conversion and Immunoregulation byProbiotics // Front. Pharmacol. – 2015. – Vol. 6. – Р. 269.76.Garate I., Garcia-Bueno В., Madrigal J.L.M. et al. Origin and consequences ofbrain toll-like receptor 4 pathway stimulation in an experimental model ofdepression // J. Neuroinflamm.
– 2011. – Vol. 8(151). – Р. 1–31.77.Gasbarrini A., Lauritano E.C., Gabrielli M. et al. Small intestinal bacterialovergrowth: diagnosis and treatment // Dig. Dis. – 2007. – Vol. 25. – Р. 237–240.78.Gasbarrini A. et al. Methodology and indications of H2-breath testing ingastrointestinal diseases: the Rome Consensus Conference // Aliment. Pharmacol.Ther. – 2009 Mar. – Vol. 29, Suppl. 1. – P. 1–49.79.Gerrard J.W., Vickers P., Gerrard C.D.
The familial incidence of allergic disease// Ann. Allergy – 1976. – Vol. 36. – Р. 5.80.Gibbs J., Ince L., Matthews L. et al. An epithelial circadian clock controlspulmonary inflammation and glucocorticoid action // Nat. Med. – 2014. –Vol.
20(8). – Р. 919–926.81.Gibson Glenn R. Fibre and effects on probiotics (the prebiotic concept) // Clin.Nutr. Suppl. – 2004. – Vol. 1(2). – P. 25–31.82.Giovannini M., Agostoni C., Riva E. et al. A randomized prospective doubleblind controlled trial on effects of long-term consumption of fermented milk98containing Lactobacillus casei in pre-school children with allergic asthma and/orrhinitis // Pediatr. Res. – 2007. – Vol. 62. – Р. 5–20.83.Grace E., Shaw C., Whelan K., Andreyev H.J. Review article: small intestinalbacterial overgrowth prevalence, clinical features, current and developingdiagnostic tests, and treatment // Aliment.
Pharmacol. Ther. – 2013, Oct. –Vol. 38(7). – Р. 88.84.Helin T., Haahtela S., Haahtela T. No effect of oral treatment with an intestinalbacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy:a placebo-controlled double-blind study // Allergy. – 2002. – Vol. 57(243).
– Р. 6.85.Hemarajata P., Gao C., Pflughoeft K.J. et al. Lactobacillus reuteri – SpecificImmunoregulatory Gene rsiR Modulates Histamine Production andImmunomodulation by Lactobacillus reuteri // J. Bacteriol. – 2013. – Vol.195(24); 55. – P. 67–76.86.Herbst T., Sichelstiel A., Schar C. et al. Dysregulation of allergic airwayinflammation in the absence of microbial colonization // Am. J. Respir. Crit. CareMed. – 2011. – Vol. 184(2). – Р.
198–205.87.Hevia A., Milani Ch., López P., Donado C.D. Allergic Patients with Long-TermAsthma Display Low Levels of Bifidobacterium adolescentis // PLoS One. –2011. – Vol. 11(2). – Р. 78.88.Hilty M., Burke C., Pedro H. et al. Disordered microbial communities inasthmatic airways // PLoS One. – 2010. – Vol. 5(1).
– Р. 78.89.Hol J., van Leer E.H., Elink-Schuurman B.E. et al. The acquisition of tolerancetoward cowʼs milk through probiotic supplementation: a randomized, controlledtrial // J. Allergy Clin. Immunol. – 2008. – Vol. 8. – Р. 121–144.90.Hoog C.M., Lindberg G., Sjoqvist U. Findings in patients with chronic intestinaldysmotility investigated by capsule endoscopy // BMC Gastroenterol. – 2007.
–Vol. 7. – P. 29.91.Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasiswith the intestinal microbiota // Nat. Rev. Immunol. – 2010. – Vol. 10. – P. 159–169.9992.Huang Y.J., Charlson E.S., Collman R.G. et al. The role of the lung microbiomein health and disease.
A National Heart, Lung, and Blood Institute workshopreport // Am. J. Respir. Crit. Care Med. – 2013, Jun. – Vol. 15; 187(12). –P. 1382–1387.93.Human Microbiome Project (HMP). US National Institutes of Health. – 2007.94.Human Microbiome Project // The NIH Common Fund. Retrieved 8 March. –2012.95.Human Microbiome Project. Home NIH Common Fund.
– 2018. – Vol. 04. –P. 15.96.Human Microbiome Project: Diversity of Human Microbes Greater ThanPreviously Predicted // Science Daily. Retrieved 8 March. – 2012.97.Huttenhower C. et al. Structure, function and diversity of the healthy humanmicrobiome // The Human Microbiome Project Consortium. Nature volume.
–2012. – Vol. 486. – Р. 207–214.98.Ismai I.H., Licciardi P.V., Tang M.L.K. Probiotic effects in allergic disease // J.Paediatr. Child Health. – 2013. – Vol. 49(709). – Р. 15.99.Isolauri E., Joensuu J., Suomalainen H. et al. Improved immunogenicity of oralDxRRV reassortant rotavirus vaccine by Lactobacillus casei GG // Vaccine. –1995. – Vol. 13. – Р. 310–312.100.Ivashkin V., Zolnikova O., Potskherashvili N. et al. A correction of a gutmicroflora composition for the allergic bronchial asthma complex therapy // Ital.J. Med. – 2018.
– Vol. 12(4). – Р. 260–264.101.Ivashkin V., Zolnikova O., Potskherashvili N. et al. Application ofprobiotics for acute respiratory tract infections // Ital. J. Med. – 2018. –Vol. 12(1). – Р. 32–38.102.Iweala O.I., Nagler C.R. Immune privilege in the gut: the establishmentand maintenance of non-responsiveness to dietary antigens and commensal flora// Immunol.
Rev. – 2006. – Vol. 213. – Р. 82–100.103.Jakobsson H.E., Abrahamsson T.R., Jenmalm M.C. et al. Decreased gutmicrobiota diversity, delayed Bacteroidetes colonisation and reduced Th1100responses in infants delivered by caesarean section // Gut. – 2012. – Vol. 63. – Р.559–566.104.Judah L. Ten Times More Microbial Cells than Body Cells in Humans? //Rosner for Microbe Magazine.
– 2014. – Vol. 9. – Р. 2.105.Juge N. How Sweet Are Our Gut Beneficial Bacteria? A Focus on ProteinGlycosylation in Lactobacillus // Int. J. Mol. Sci. – 2018. – Vol. 19(1). – Р. 136.106.Jutel M., Akdis M., Akdis C.A. Histamine, histamine receptors and theirrole in immune pathology // Clin. Exp. Allergy. – 2009. – Vоl. 39. – Р. 1786–1800.107.Kalliomäki M., Kirjavainen P., Eerola E. et al. Distinct patterns of neonatalgut microflora in infants in whom atopy was and was not developing // J. AllergyClin. Immunol.
– 2001. – Vol. 107(1). – Р. 29–34.108.Kalliomaki M., Salminen S., Poussa T., Isolauri E. Probiotics during thefirst 7 years of life: a cumulative risk reduction of eczema in a randomized,placebo-controlled trial // J. Allergy Clin. Immunol. – 2007. – Vol. 119(10). –Р. 19–21.109.Kalliomaki M., Salminen S., Poussa T. et al. Probiotics and prevention ofatopic disease. 4-year follow-up of a randomized placebo-controlled trial //Lancet. – 2003. – Vol.
361. – Р. 69–71.110.Kerlin P., Wong L. Breath hydrogen testing in bacterial overgrowth of thesmall intestine // Gastroenterology. – 1988. – Vol. 95. – Р. 982–988.111.Khoshini R. et al. A systematic review of diagnostic tests for smallintestinal bacterial overgrowth // Dig. Dis.
Sci. – 2008, Jun. – Vol. 53(6). – P.1443–1454.112.Kirjavainen P.V., Gibson G.R. Healthy gut microflora and allergy: factorsinfluencing development of the microbiota // Ann. Med. – 1999. – Vol. 31(2). –Р. 88–92.113.Kivit S. de, Tobin M.C., De Meo M.T. et al. In vitro evaluation of intestinalepithelial TLR activation in preventing food allergic responses // Clin.Immunol.
– 2014. – Vol. 154(2). – Р. 91–99.101114.Ko F.W., Leung T.F., Hui D.S. et al. Asthma Control Test correlates wellwith the treatment decisions made by asthma specialists // Respirology. – 2009. –Vol. 14(4); 5. – Р. 59–66.115.Koenig J.E., Spor A., Scalfone N. et al. Succession of microbial consortiain the developing infant gut microbiome // Proc. Natl. Acad. Sci. U.S.A. –2011. – Vol. 108(Suppl.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
